{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Courbe ROC : Questions médicales les plus fréquentes",
"headline": "Courbe ROC : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Courbe ROC : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-27",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Courbe ROC"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Méthodologie en recherche épidémiologique",
"url": "https://questionsmedicales.fr/mesh/D015340",
"about": {
"@type": "MedicalCondition",
"name": "Méthodologie en recherche épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015340",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.445"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Courbe ROC",
"alternateName": "ROC Curve",
"code": {
"@type": "MedicalCode",
"code": "D012372",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhen Chen",
"url": "https://questionsmedicales.fr/author/Zhen%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, MD, USA."
}
},
{
"@type": "Person",
"name": "Oliver Kuss",
"url": "https://questionsmedicales.fr/author/Oliver%20Kuss",
"affiliation": {
"@type": "Organization",
"name": "Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany."
}
},
{
"@type": "Person",
"name": "Annika Hoyer",
"url": "https://questionsmedicales.fr/author/Annika%20Hoyer",
"affiliation": {
"@type": "Organization",
"name": "Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "School of Mathematics and Statistics, North China University of Water Resources and Electric Power, Zhengzhou, China."
}
},
{
"@type": "Person",
"name": "Soutik Ghosal",
"url": "https://questionsmedicales.fr/author/Soutik%20Ghosal",
"affiliation": {
"@type": "Organization",
"name": "Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, MD, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors.",
"datePublished": "2023-05-12",
"url": "https://questionsmedicales.fr/article/37182669",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2023.05.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utility of vaginal vault cytology in the local recurrence of cervical cancer.",
"datePublished": "2023-04-20",
"url": "https://questionsmedicales.fr/article/37081439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12905-023-02371-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36649177",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DCR.0000000000002551"
}
},
{
"@type": "ScholarlyArticle",
"name": "Symptoms and diagnosis of local recurrence after rectal cancer treatment.",
"datePublished": "2022-08-13",
"url": "https://questionsmedicales.fr/article/35968829",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0284186X.2022.2106794"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological Characteristics of Anastomotic Recurrence After Curative Resection for Colorectal Cancer: Comparison With Nonanastomotic Local Recurrences.",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36649156",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DCR.0000000000002566"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Méthodologie en recherche épidémiologique",
"item": "https://questionsmedicales.fr/mesh/D015340"
},
{
"@type": "ListItem",
"position": 6,
"name": "Courbe ROC",
"item": "https://questionsmedicales.fr/mesh/D012372"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Courbe ROC - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Courbe ROC",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Courbe ROC",
"description": "Qu'est-ce qu'une courbe ROC ?\nComment interpréter une courbe ROC ?\nQuelle est l'aire sous la courbe ROC ?\nQuels tests utilisent la courbe ROC ?\nQuelle est l'importance de la courbe ROC ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Courbe ROC",
"description": "Les courbes ROC montrent-elles des symptômes ?\nPeut-on utiliser la courbe ROC pour des symptômes spécifiques ?\nComment la courbe ROC aide-t-elle au diagnostic des symptômes ?\nLes symptômes influencent-ils la courbe ROC ?\nPeut-on comparer des symptômes avec la courbe ROC ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Courbe ROC",
"description": "La courbe ROC aide-t-elle à la prévention des maladies ?\nComment la courbe ROC influence-t-elle les programmes de prévention ?\nPeut-on utiliser la courbe ROC pour des stratégies de prévention ?\nLes tests de dépistage sont-ils évalués par la courbe ROC ?\nLa courbe ROC peut-elle aider à prioriser les interventions préventives ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Courbe ROC",
"description": "La courbe ROC aide-t-elle à choisir un traitement ?\nPeut-on utiliser la courbe ROC pour évaluer des traitements ?\nComment la courbe ROC influence-t-elle les décisions de traitement ?\nLes résultats des tests influencent-ils les traitements ?\nLa courbe ROC est-elle utilisée dans les essais cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Courbe ROC",
"description": "La courbe ROC peut-elle prédire des complications ?\nComment la courbe ROC aide-t-elle à éviter des complications ?\nLes complications influencent-elles la courbe ROC ?\nPeut-on utiliser la courbe ROC pour évaluer des risques de complications ?\nLa courbe ROC est-elle utile pour les complications post-opératoires ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Courbe ROC",
"description": "La courbe ROC évalue-t-elle des facteurs de risque ?\nComment la courbe ROC aide-t-elle à identifier des facteurs de risque ?\nLes facteurs de risque influencent-ils la courbe ROC ?\nPeut-on utiliser la courbe ROC pour évaluer des tests liés à des facteurs de risque ?\nLa courbe ROC aide-t-elle à prioriser les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce qu'une courbe ROC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un graphique qui montre la sensibilité et la spécificité d'un test à différents seuils."
}
},
{
"@type": "Question",
"name": "Comment interpréter une courbe ROC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une courbe proche du coin supérieur gauche indique un bon test, tandis qu'une diagonale indique un test aléatoire."
}
},
{
"@type": "Question",
"name": "Quelle est l'aire sous la courbe ROC ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'aire sous la courbe (AUC) quantifie la performance globale d'un test, allant de 0 à 1."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent la courbe ROC ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est utilisée pour évaluer des tests de dépistage, comme ceux pour le diabète ou le cancer."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la courbe ROC ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à choisir le meilleur seuil de décision pour maximiser la détection des maladies."
}
},
{
"@type": "Question",
"name": "Les courbes ROC montrent-elles des symptômes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles évaluent la performance des tests, pas les symptômes eux-mêmes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à évaluer des tests pour des symptômes particuliers, comme la douleur thoracique."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC aide-t-elle au diagnostic des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de déterminer la fiabilité d'un test pour des symptômes spécifiques en ajustant le seuil."
}
},
{
"@type": "Question",
"name": "Les symptômes influencent-ils la courbe ROC ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, car la prévalence des symptômes affecte la sensibilité et la spécificité des tests."
}
},
{
"@type": "Question",
"name": "Peut-on comparer des symptômes avec la courbe ROC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en utilisant des tests différents pour des symptômes similaires, on peut comparer leur efficacité."
}
},
{
"@type": "Question",
"name": "La courbe ROC aide-t-elle à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en évaluant l'efficacité des tests de dépistage qui peuvent prévenir des maladies."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC influence-t-elle les programmes de prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier les tests les plus efficaces pour le dépistage précoce dans les programmes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour des stratégies de prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer les tests qui aident à identifier les populations à risque pour des interventions."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils évalués par la courbe ROC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la courbe ROC est un outil clé pour évaluer la performance des tests de dépistage."
}
},
{
"@type": "Question",
"name": "La courbe ROC peut-elle aider à prioriser les interventions préventives ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en identifiant les tests les plus fiables, elle aide à prioriser les interventions de santé."
}
},
{
"@type": "Question",
"name": "La courbe ROC aide-t-elle à choisir un traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en évaluant l'efficacité des tests qui guident les décisions de traitement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour évaluer des traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle évalue les tests diagnostiques, pas les traitements eux-mêmes."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC influence-t-elle les décisions de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de choisir des tests plus fiables, ce qui peut influencer le choix du traitement."
}
},
{
"@type": "Question",
"name": "Les résultats des tests influencent-ils les traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests fiables peuvent mener à des traitements plus appropriés et efficaces."
}
},
{
"@type": "Question",
"name": "La courbe ROC est-elle utilisée dans les essais cliniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer la performance des tests utilisés dans les essais cliniques pour des traitements."
}
},
{
"@type": "Question",
"name": "La courbe ROC peut-elle prédire des complications ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle évalue la performance des tests, pas les complications elles-mêmes."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC aide-t-elle à éviter des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "En identifiant des tests fiables, elle permet un diagnostic précoce, réduisant le risque de complications."
}
},
{
"@type": "Question",
"name": "Les complications influencent-elles la courbe ROC ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, car la prévalence des complications peut affecter la sensibilité des tests."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour évaluer des risques de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en évaluant des tests qui prédisent des complications, on peut ajuster les soins."
}
},
{
"@type": "Question",
"name": "La courbe ROC est-elle utile pour les complications post-opératoires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut évaluer des tests qui prédisent des complications après une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "La courbe ROC évalue-t-elle des facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle évalue la performance des tests, pas les facteurs de risque eux-mêmes."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC aide-t-elle à identifier des facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "En évaluant des tests qui détectent des maladies liées à des facteurs de risque spécifiques."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque influencent-ils la courbe ROC ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la prévalence des facteurs de risque peut affecter la sensibilité et la spécificité des tests."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour évaluer des tests liés à des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'évaluer l'efficacité des tests pour détecter des maladies liées à ces facteurs."
}
},
{
"@type": "Question",
"name": "La courbe ROC aide-t-elle à prioriser les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en identifiant les tests les plus fiables, elle aide à prioriser les facteurs de risque à surveiller."
}
}
]
}
]
}
To determine the risk factors for local of adult patients treated for desmoid tumors by cryoablation....
Eighty-four patients treated for nonabdominopelvic desmoid tumors by cryoablation from July 2012 to July 2020 were included in a retrospective study. The population was composed of 64 women (76.19%) a...
Local relapse was found in 19 (22.62%) of 84 patients. The 12-, 24-, and 36-month progression-free survival rates were 89% (95% confidence interval [CI], 79-94), 74% (95% CI, 60-83), and 68% (95% CI, ...
The local recurrence of desmoid tumors after cryoablation depends on a number of prognostic factors, in particular, a non-abdominal wall location of the tumor and previous local treatment such as surg...
In Japan, 8000 women were newly diagnosed with cervical cancer in 2018. The healthcare insurance policy in Japan allows physicians to utilize vaginal volt cytology tests and serum biomarker measuremen...
From January 2009 to December 2015, the medical records of patients with recurrence who were initially diagnosed with International Federation of Gynecology and Obstetrics stage I-III cervical cancer ...
In the study period, 84 of the 981 patients experienced recurrence, and 88.1% had an asymptomatic recurrence. The disease-free interval was not related to the recurrence site. In univariate analysis, ...
In this retrospective study, routine imaging analysis and serum biomarker measurement did not contribute to patient prognosis after recurrence. In contrast, vaginal vault cytology can improve survival...
Total mesorectal excision is the standard surgical procedure for rectal cancer treatment. Several studies have shown a close correlation between the prognosis of patients with rectal cancer and the co...
To assess the correlation between macroscopic assessment of mesorectal excision and long-term oncological outcomes....
Retrospective analysis of an Institutional Review Board-approved database....
Tertiary referral center....
Patients with rectal cancer who were operated on between March 2016 and October 2019 were classified into 3 groups based on the mesorectal specimen quality: complete, near complete, and incomplete. On...
Relationship between total mesorectal excision and local and distant recurrence rates in patients with rectal cancer....
A total of 124 patients (35.5% females) were included in the analysis, with a mean age of 58.1 (SD 12) years and a mean BMI of 26.4 (SD 4.59) kg/m². Neoadjuvant chemoradiation was administered to 71% ...
Retrospective, single-center study with relatively short follow-up....
In the era of a multidisciplinary approach and extensive use of neoadjuvant therapy, macroscopic completeness of total mesorectal excision may not be as valuable a prognosticator as in the past. Large...
ANTECEDENTES:La escisión total desl mesorrecto es el estándar de oro para el tratamiento del cáncer de recto. Varios estudios han demostrado una estrecha correlación entre el pronóstico de los pacient...
The prognosis for local recurrence after rectal cancer treatment is poor. A minority of patients are eligible for surgery with curative intent, which could possibly be improved by earlier detection. T...
In a population-based retrospective cohort (cohort A), all patients who had undergone resection surgery for rectal cancer in the region of Västra Götaland, Sweden, diagnosed 2010-2014, were identified...
Cohort A consisted of 1208 patients, out of whom 78 (6%) were diagnosed with local recurrence. Forty-six patients were diagnosed between scheduled follow-up visits. Fifty-eight patients were symptomat...
A majority of patients with local recurrence were diagnosed outside of the scheduled follow-up. Most of the patients were symptomatic at diagnosis. Symptoms were common in patients after rectal cancer...
Anastomotic recurrence is thought to be caused by implantation of tumor cells to the anastomotic line; however, its risk factors and prognostic significance remain unclear....
This study aimed to clarify the risk factors for anastomotic recurrence in colorectal cancer and assess the prognosis in comparison to nonanastomotic local recurrence....
A single-center retrospective observational study....
The medical records of the study participants were retrospectively collected from the Department of Surgical Oncology at the University of Tokyo Hospital database....
This study included 1584 patients with colorectal cancer who underwent surgical resection between January 2005 and December 2017. We focused on 15 patients who had an anastomotic recurrence....
The main outcome measures were the risk factors of anastomotic recurrence at the primary resection and prognosis data in comparison to that of nonanastomotic local recurrence....
There were 15 patients (0.95%) with anastomotic recurrence and 35 (2.21%) with nonanastomotic local recurrence. Univariate analysis revealed that lymph node metastasis and advanced T stage are the ris...
The small number of patients with anastomotic recurrence is a major limitation of this study. Additionally, the retrospective study design may have increased the risk of selection bias....
Lymph node metastasis and advanced T stage were associated with anastomotic recurrence. The prognosis of patients with anastomotic recurrence was similar to that with resected nonanastomotic local rec...
ANTECEDENTES:Se cree que la recurrencia anastomótica es causada por la implantación de células tumorales en la línea anastomótica; sin embargo, los factores de riesgo asociados y el significado en cua...
Accurate preoperative localization of tumor-bearing lesions is crucial for the successful surgical management of suspected recurrent parathyroid carcinoma. The purpose of this study was to evaluate th...
Twenty-nine patients with suspected recurrent parathyroid carcinoma were included in this retrospective cohort study. Patients underwent preoperative 99m Tc-MIBI SPECT/CT and cervical ultrasound. The ...
Of the 29 patients, histopathological results revealed 48 metastases/recurrent lesions in 26 patients. The diagnostic value of 99m Tc-MIBI SPECT/CT, cervical ultrasound, and the two modalities in comb...
The combined use of 99m Tc-MIBI SPECT/CT and cervical ultrasound is the most efficient strategy in the diagnosis of parathyroid carcinoma relapse, whereas 99m Tc-MIBI SPECT/CT is the preferred method ...
To investigate the local recurrence rates of men treated with Mohs microsurgery (MMS) for penile carcinoma. The secondary outcome was surgical complications from the MMS procedure or the subsequent re...
All patients from 2010 to 2020 with penile carcinoma at our institution were seen in a multidisciplinary setting. Patients with Ta, Tis, T1, and T2 disease were considered candidates for MMS. Clinical...
A total of 43 patients met inclusion criteria. The median age at diagnosis was 64 years. Stage distribution was Ta in 4.7%, Tis in 58.1%, T1a in 14.0%, T1b in 7.0%, and T2 in 16.3%. No patients had a ...
MMS provides effective local control for Ta, Tis, and T1 penile cancer with an overall local recurrence rate of 2% and an acceptable complication rate. A multi-disciplinary team involving urologic onc...
Phyllodes tumours of the breast are rare fibroepithelial neoplasms with a propensity for recurrence. While surgical excision remains the standard of care, the optimal margin width is an area of active...
We conducted a retrospective, cohort study of patients with phyllodes tumours treated at our institution between 2003 and 2021. Demographic, histopathological, and recurrence data were captured; malig...
Of 187 patients with phyllodes tumours, 82.9% (n = 155) were classified as benign while 17.1% (n = 32) were borderline. Initial surgical margins were positive in 26.2% (n = 49), < 2 mm in 50.8% (n = 9...
In this large cohort of benign and borderline phyllodes tumours, positive resection margins and not margin width at the initial surgery were associated with a increased recurrence. Individualization o...
Patients with locally recurrent rectal cancer (LRRC) generally have poor prognosis, especially those who have (a history of) distant metastases. The aim of this study was to investigate the impact of ...
Consecutive patients with surgically treated LRRC between 2005 and 2019 in two tertiary referral hospitals were retrospectively analysed. Oncological survival of patients without distant metastases we...
A total of 535 LRRC patients were analysed, of whom 398 (74%) had no (history of) metastases, 22 (4%) had synchronous metastases with the primary tumour, 44 (8%) had metachronous metastases, and 71 (1...
LRRC patients with synchronous distant metastases undergoing curative surgery have relatively poor prognosis. However, LRRC patients with a history of distant metastases diagnosed nearby the primary t...
The influence of various morphological, anatomical, genetic and other factors on the local recurrence-free survival of patients who have undergone different renal cell cancer (RCC) treatment is still ...
